We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

We are aware of recent press reports concerning the link between two drugs for osteoporosis (alendronate and zoledronate) and the occurrence of a heart condition characterized by an irregular heart […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Thank you for participating in the Living Well with Osteoporosis program Osteoporosis Canada depends on the generous support of donors to help realize its vision and mission.  Please consider making […]

Thank you for having your group attend Bone Health 101 Osteoporosis Canada depends on the generous support of donors to help realize its vision and mission.  Please consider making a […]

Thank you for joining our Support Group Osteoporosis Canada depends on the generous support of donors to help realize its vision and mission.  Please consider making a donation to help […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

Recommendations from Osteoporosis Canada Rapid Response Team We are aware of the recent study by Dr. Meryl Leboff that concluded vitamin D3 supplementation of 2000 IU daily does not significantly […]

Canada’s new Food Guide will be released on Tuesday Jan 22nd. It is a modern approach to promoting healthy eating, making healthier eating choices easier for all Canadians. This new […]